| scholarly article | Q13442814 |
| P2093 | author name string | Satoshi Tanaka | |
| Masabumi Shibuya | |||
| Yuki Kataoka | |||
| Kazuki Nakao | |||
| Kenji Nakamura | |||
| Motoya Katsuki | |||
| Shunichi Morikawa | |||
| Sachie Hiratsuka | |||
| Yoshiro Maru | |||
| P2860 | cites work | A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells | Q24291278 |
| Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor | Q24294262 | ||
| Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family | Q24303496 | ||
| The phosphorylated 1169-tyrosine containing region of flt-1 kinase (VEGFR-1) is a major binding site for PLCgamma | Q24312773 | ||
| Vascular endothelial growth factor B, a novel growth factor for endothelial cells | Q24312842 | ||
| Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor | Q24320710 | ||
| Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) | Q24321792 | ||
| Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1 | Q24323317 | ||
| A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases | Q24336293 | ||
| Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor | Q24560244 | ||
| Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4 | Q24568018 | ||
| Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells | Q24679724 | ||
| Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins | Q28186603 | ||
| Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR | Q28238949 | ||
| An ECM substratum allows mouse mesodermal cells isolated from the primitive streak to exhibit motility similar to that inside the embryo and reveals a deficiency in the T/T mutant cells | Q28295983 | ||
| Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice | Q28504776 | ||
| Eomesodermin is required for mouse trophoblast development and mesoderm formation | Q28507697 | ||
| Vascular endothelial growth factor-B-deficient mice display an atrial conduction defect | Q74215451 | ||
| Progressive lineage analysis by cell sorting and culture identifies FLK1+VE-cadherin+ cells at a diverging point of endothelial and hemopoietic lineages | Q74378538 | ||
| MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis | Q78423896 | ||
| A role for hematopoietic stem cells in promoting angiogenesis | Q28508896 | ||
| Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium | Q28512027 | ||
| A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1) | Q28569749 | ||
| Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium | Q28587604 | ||
| Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia | Q28589545 | ||
| Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice | Q28593600 | ||
| A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF | Q28646512 | ||
| Mechanisms of angiogenesis | Q29547485 | ||
| Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene | Q29547732 | ||
| Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele | Q29547733 | ||
| The biology of vascular endothelial growth factor | Q29615946 | ||
| Genomic organization of the flt-1 gene encoding for vascular endothelial growth factor (VEGF) receptor-1 suggests an intimate evolutionary relationship between the 7-Ig and the 5-Ig tyrosine kinase receptors | Q32077469 | ||
| Membrane fixation of vascular endothelial growth factor receptor 1 ligand-binding domain is important for vasculogenesis and angiogenesis in mice | Q33551759 | ||
| Origin of hematopoietic progenitors during embryogenesis | Q34244355 | ||
| Structure and function of VEGF/VEGF-receptor system involved in angiogenesis | Q34246910 | ||
| Mouse gastrulation: the formation of a mammalian body plan | Q34452578 | ||
| Clonal analysis of epiblast fate during germ layer formation in the mouse embryo. | Q34740870 | ||
| The role of VEGF in normal and neoplastic hematopoiesis | Q35052515 | ||
| Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues | Q35596585 | ||
| Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment | Q37426670 | ||
| A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit | Q37604867 | ||
| A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3'-kinase activation and endothelial cell migration | Q40392328 | ||
| Endothelial receptor tyrosine kinases involved in angiogenesis. | Q40400431 | ||
| The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells | Q42704934 | ||
| Antiangiogenic effect by SU5416 is partly attributable to inhibition of Flt-1 receptor signaling. | Q42807217 | ||
| VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells | Q42815794 | ||
| SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types | Q42820704 | ||
| Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. | Q43592482 | ||
| Guidance of cell migration by the Drosophila PDGF/VEGF receptor | Q43762442 | ||
| Autocrine-paracrine VEGF loops potentiate the maturation of megakaryocytic precursors through Flt1 receptor. | Q44198511 | ||
| The somitogenetic potential of cells in the primitive streak and the tail bud of the organogenesis-stage mouse embryo | Q45097055 | ||
| Developmental control of blood cell migration by the Drosophila VEGF pathway | Q47070051 | ||
| Significant expression of vascular endothelial growth factor/vascular permeability factor in mouse ascites tumors | Q47944895 | ||
| Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice. | Q51089819 | ||
| Vascularization of the mouse embryo: A study of flk‐1, tek, tie, and vascular endothelial growth factor expression during development | Q52208633 | ||
| Regionalisation of cell fate and morphogenetic movement of the mesoderm during mouse gastrulation. | Q52212199 | ||
| The formation of mesodermal tissues in the mouse embryo during gastrulation and early organogenesis. | Q52258265 | ||
| Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors | Q59081200 | ||
| The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities | Q59261168 | ||
| The orderly allocation of mesodermal cells to the extraembryonic structures and the anteroposterior axis during gastrulation of the mouse embryo | Q60982889 | ||
| Two molecules related to the VEGF receptor are expressed in early endothelial cells during avian embryonic development | Q70474300 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| Vascular endothelial growth factor receptor 2 | Q21496011 | ||
| FMS-like tyrosine kinase 1 | Q21990307 | ||
| Vascular endothelial growth factor A | Q21992409 | ||
| P304 | page(s) | 355–363 | |
| P577 | publication date | 2005-01-01 | |
| P1433 | published in | Molecular and Cellular Biology | Q3319478 |
| P1476 | title | Vascular endothelial growth factor A (VEGF-A) is involved in guidance of VEGF receptor-positive cells to the anterior portion of early embryos | |
| P478 | volume | 25 |
| Q34836822 | A fusion protein composed of receptor binding domain of vascular endothelial growth factor-A and constant region fragment of antibody: angiogenesis antagonistic activity |
| Q48194235 | Accelerated growth of hemangioblastoma in pregnancy: the role of proangiogenic factors and upregulation of hypoxia-inducible factor (HIF) in a non-oxygen-dependent pathway |
| Q92017451 | Associations between microRNA (miR-25, miR-32, miR-125, and miR-222) polymorphisms and recurrent implantation failure in Korean women |
| Q38064445 | Collective epithelial and mesenchymal cell migration during gastrulation |
| Q38542115 | Diabetic Retinopathy: Vascular and Inflammatory Disease. |
| Q36141653 | Duplicate VegfA genes and orthologues of the KDR receptor tyrosine kinase family mediate vascular development in the zebrafish |
| Q64374719 | Endothelial FAM3A positively regulates post-ischaemic angiogenesis |
| Q38121852 | Endothelial cell motility, coordination and pattern formation during vasculogenesis |
| Q37356898 | Evaluation of antiangiogenic and antiproliferative potential of the organic extract of green algae Chlorella pyrenoidosa |
| Q30863814 | Gene expression profiles of sporadic canine hemangiosarcoma are uniquely associated with breed |
| Q33722070 | Gene-gene interactions and gene polymorphisms of VEGFA and EG-VEGF gene systems in recurrent pregnancy loss |
| Q37885073 | Genetic association studies of angiogenesis- and vasoconstriction-related genes in women with recurrent pregnancy loss: a systematic review and meta-analysis |
| Q36725906 | In vitro and in vivo evidence for lack of endovascular remodeling by third trimester trophoblasts. |
| Q36902254 | Lack of VEGFR2 signaling causes maldevelopment of the intestinal microvasculature and facilitates necrotizing enterocolitis in neonatal mice |
| Q38993817 | Maternal genetic polymorphisms and unexplained recurrent miscarriage: a systematic review and meta-analysis |
| Q37678807 | Mediators of ocular angiogenesis |
| Q34183087 | Molecular MRI assessment of vascular endothelial growth factor receptor-2 in rat C6 gliomas |
| Q36527213 | Ras signaling directs endothelial specification of VEGFR2+ vascular progenitor cells. |
| Q37428798 | Role of VEGF in organogenesis |
| Q34309067 | Survival of Hoxa13 homozygous mutants reveals a novel role in digit patterning and appendicular skeletal development |
| Q90054489 | The association of Q472H variant in the KDR gene with recurrent pregnancy loss in Southern Iran: A case-control study |
| Q29617256 | VEGF receptor signalling - in control of vascular function |
| Q55379904 | Vascular Endothelial Growth Factor B and Its Signaling. |
| Q36489757 | Vascular endothelial growth factor (VEGF)-Receptor2: its biological functions, major signaling pathway, and specific ligand VEGF-E. |
| Q27028225 | Vitreous mediators in retinal hypoxic diseases |
Search more.